Breakout Stocks of Week 27 @ FRA
NASDAQ was up last week (week 26) by 0.244% ending at 17,732.60 points after gaining 43.24 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are QIAGEN N.V. FRA:QIA. This stock has had a buy signal since Jun 28, 2024 when the price was 38.55€ , but have so far fallen 0% to 38.55€. Some other companies are on our watchlist to, among these are Ubs(lux)fund Solutions – Msci Emu Ucits Etf(eur)a-dis FRA:UIM4 Ishares Msci Emu Esg Screened Ucits Etf Eur (acc) FRA:SLMA Ishares Vii Plc - Ishares Core Euro Stoxx 50 Ucits Etf FRA:SXRT and Vonovia SE FRA:VNA which all got a breakout pattern emerging.
| Date | Company | Price | Change |
|---|---|---|---|
| Qiagen N.v. | 38.55€ | 37.81€ ( 2nd Jul 2024 ) | -1.92% |
| Ubs(lux)fund Solutions – Msci Emu Ucits Etf(eur)a-... | 163.46€ | 163.96€ ( 2nd Jul 2024 ) | 0.306% |
| Ishares Msci Emu Esg Screened Ucits Etf Eur (acc) | 8.20€ | 8.21€ ( 2nd Jul 2024 ) | 0.146% |
| Ishares Vii Plc - Ishares Core Euro Stoxx 50 Ucits... | 180.40€ | 180.82€ ( 2nd Jul 2024 ) | 0.233% |
| Vonovia Se | 26.55€ | 26.24€ ( 2nd Jul 2024 ) | -1.17% |
The QIAGEN N.V. stock price gained 0.508% on the last trading day (Friday, 28th Jun 2024), rising from 38.36€ to 38.55€. During the last trading day the stock fluctuated 1.74% from a day low at 38.20€ to a day high of 38.87€. The price has risen in 7 of the last 10 days but is still down by -2.9% for this period. Volume fell on the last day by -133 thousand shares and in total, 610 thousand shares were bought and sold for approximately 23.51€ million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About QIAGEN N.V.:
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.
Ubs(lux)fund Solutions – Msci Emu Ucits Etf(eur)a-dis
FRA:UIM4The Ubs(lux)fund Solutions – Msci Emu ETF price fell by -0.232% on the last day (Friday, 28th Jun 2024) from 163.84€ to 163.46€. It has now fallen 4 days in a row. During the last trading day the ETF fluctuated 0.662% from a day low at 163.22€ to a day high of 164.30€. The price has fallen in 6 of the last 10 days but is still up by 0.76% over the past 2 weeks. Volume has increased on the last day by 20 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 20 thousand shares were bought and sold for approximately 3.26€ million.
Ubs(lux)fund Solutions – Msci Emu holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Ishares Msci Emu Esg Screened Ucits Etf Eur (acc)
FRA:SLMAThe Ishares Msci Emu Esg Screened Ucits Etf ETF price fell by -0.0610% on the last day (Friday, 28th Jun 2024) from 8.20€ to 8.20€. It has now fallen 4 days in a row. During the last trading day the ETF fluctuated 1.47% from a day low at 8.18€ to a day high of 8.30€. The price has fallen in 6 of the last 10 days but is still up by 1% over the past 2 weeks. Volume has increased on the last day by 462 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 514 thousand shares were bought and sold for approximately 4.22€ million.
Ishares Msci Emu Esg Screened Ucits Etf holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Ishares Vii Plc - Ishares Core Euro Stoxx 50 Ucits Etf
FRA:SXRTThe Ishares Vii Plc - Ishares Core Euro ETF price fell by -0.111% on the last day (Friday, 28th Jun 2024) from 180.60€ to 180.40€. It has now fallen 4 days in a row. During the last trading day the ETF fluctuated 0.83% from a day low at 179.80€ to a day high of 181.30€. The price has fallen in 6 of the last 10 days but is still up by 1.27% over the past 2 weeks. Volume has increased on the last day by 7 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 13 thousand shares were bought and sold for approximately 2.26€ million.
Ishares Vii Plc - Ishares Core Euro holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
The Vonovia SE stock price gained 0.302% on the last trading day (Friday, 28th Jun 2024), rising from 26.47€ to 26.55€. During the last trading day the stock fluctuated 1.63% from a day low at 26.41€ to a day high of 26.84€. The price has been going up and down for this period, and there has been a -1.59% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 157 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately 64.31€ million.
Vonovia SE holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Vonovia SE:
Vonovia SE operates as an integrated residential real estate company in Europe. It operates through five segments: Rental, Value-Add, Recurring Sales, Development, and Deutsche Wohnen. The company offers property management services; apartments and property-related services; and value-added services, including maintenance and modernization of properties, craftsmen and residential environment organization, residential environment organization, condominium administration, cable TV, metering, energy supply, and insurances services. It also engages in the sale of individual condominiums and single-family houses; and project development activities. As of December 31, 2021, the company had 565,334 residential units; 168,015 garages and parking spaces; and 9,289 commercial units, as well as managed 71,173 residential units for other owners in Germany, Austria, and Sweden. The company was formerly known as Deutsche Annington Immobilien SE and changed its name to Vonovia SE in August 2015. Vonovia SE was founded in 1998 and is headquartered in Bochum, Germany.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
